The technology institute for the Brazilian state of Parana, which has signed an agreement to produce Russia’s Sputnik V coronavirus vaccine, said it plans to conduct phase-three trials on 10,000 volunteers in Brazil at the start of next year.

Jorge Callado, head of Parana’s Technology Institute, known as Tecpar, said approval for the trial will be requested of Brazil’s health regulator ANVISA by the end of this month. Doses will be imported for the tests and Tecpar plans to produce the vaccine for Brazil’s market in the second half of 2021, he said.



Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.